🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

24 recruiting trials

for Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)

Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma NCT07780838Phase 21 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Cisplatin, Computed Tomography, Durvalumab, Gemcitabine Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer NCT07614061Phase 11 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: BTC-Ag-T (ACH-AgT001), Cyclophosphamide and Fludarabine Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer NCT05184400n/a1 site📍 Herlev Herlev and Gentofte Hospital Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors NCT07334119Phase 17 sites📍 Darlinghurst📍 Randwick📍 Waratah Myeloid Therapeutics · Tests: MT-304, MT-304 + Nivolumab Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) NCT06101277NA1 site📍 Sacramento University of California, Davis · Tests: Ablative local therapy Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors NCT06239194Phase 1, Phase 26 sites📍 Denver📍 Miami📍 Boston ModeX Therapeutics, An OPKO Health Company · Tests: MDX2001 Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers NCT07337850n/a1 site📍 Mumbai Tata Memorial Centre · Tests: gallium-68-Fibroblast Activation Protein Inhibitor Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer NCT07265674Phase 318 sites📍 Duarte📍 Orange📍 Santa Monica J-Pharma Co., Ltd. · Tests: Nanvuranlat, Physician's Best Choice Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors NCT07726446Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: PD-1 and chemotherapy, cryoablation A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02) NCT07221253Phase 3183 sites📍 Birmingham📍 Phoenix📍 Tucson AstraZeneca · Tests: Rilvegostomig, Durvalumab, Gemcitabine/Cisplatin A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening NCT07176962n/a1 site📍 Shanghai Yingbin Liu, MD, PhD, FACS The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer NCT03637569n/a1 site📍 Seoul Samsung Medical Center · Tests: Measurement of triceps skinfold thickness Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer NCT07025174Phase 21 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: PD-1/CTLA-4 Dual Functional Antibody, Gemcitabine, Cisplatin, Anlotinib, Oxaliplatin + 5-Fluorouracil/Leucovorin A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors NCT06270706Phase 122 sites📍 New Haven📍 Atlanta📍 Grand Rapids Pliant Therapeutics, Inc. · Tests: PLN-101095, PLN-101095, PLN-101095, PLN-101095, PLN-101095 To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors NCT07594964Phase 12 sites📍 Beijing📍 Beijing Shenzhen Xinhe Biomedical · Tests: XH001 Injection, mFOLFIRINOX Treatment Regimen Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer NCT06282575Phase 3185 sites📍 Duarte📍 Lone Tree📍 Orlando Jazz Pharmaceuticals · Tests: Zanidatamab, Cisplatin, Gemcitabine, Pembrolizumab, Durvalumab Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer NCT06852287Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: chemotherapy with gemcitabine and oxaliplatin; small molecure TKI lenvatinib; immune-checkpoint inhibitor toripalimab. Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: PICO G2 4k Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer NCT07641036Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: EB-HC01 dual-target CARNK cells, Fludarabine, Cyclophosphamide Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases NCT05285358Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Cisplatin, Gemcitabine, Nab-paclitaxel, Quality-of-Life Assessment, Questionnaire Administration Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types NCT05000294Phase 1, Phase 21 site📍 Gainesville University of Florida · Tests: Atezolizumab, Tivozanib Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients NCT06529718Phase 242 sites📍 Amiens📍 Angers📍 Avignon UNICANCER · Tests: Ivonescimab, FOLFOX regimen Bile Omics for Diagnosing Indeterminate Biliary Strictures NCT07007832n/a1 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Endoscopic retrograde cholangiopancreatography
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy